Perfil
Mats Lindskog currently works at OncoZenge AB, as Independent Director from 2025.
Mr. Lindskog also formerly worked at ACAP Invest AB, as Chief Executive Officer in 2012.
Mr. Lindskog received his graduate degree and doctorate degree from Royal Institute of Technology and undergraduate degree from Blekinge Tekniska Högskola.
Cargos activos de Mats Lindskog
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCOZENGE AB | Director/Miembro de la Junta | 01/01/2025 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Mats Lindskog.
| Empresas | Cargo | Fin |
|---|---|---|
| WNTRESEARCH AB | Director/Miembro de la Junta | - |
| ACAP INVEST AB | Director Ejecutivo | - |
Formación de Mats Lindskog.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
ACAP Invest AB
ACAP Invest AB Investment Trusts/Mutual FundsMiscellaneous Provides investment services | Miscellaneous |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wntresearch AB
Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Blekinge Tekniska Högskola
Blekinge Tekniska Högskola Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
- Bolsa de valores
- Insiders
- Mats Lindskog
















